Serena Group

follow us on FacebookLinkedInTwitter

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon sign up for the latest news

Hyperbaric Oxygen Therapy | SerenaGroupHyperbaric oxygen therapy is a medical treatment administered by delivering 100% oxygen at pressures greater than atmospheric (sea level) pressure to a patient in an enclosed chamber.

Hyperbaric oxygen acts as a drug, eliciting varying levels of response at different treatment depths, durations, and dosages. It has proven effective as adjunctive therapy for specifically indicated conditions.

Specially designed “chambers” safely administer the oxygen needed. The patient’s plasma is thereby saturated with oxygen and this increased oxygen activity enhances the body’s ability to heal:

How it works

Approved Hyperbaric Indications

Areas of Current Reasearch in Hyperbaric Oxygen Therapy

The Program

The Serena Group Team is working to provide the most comprehensive treatment for acute and chronic wounds across all patient care settings, from the latest advances in chronic wound treatment and prevention to clinical research and hyperbaric medicine.
We have assembled comprehensive options for our hospital clients that offers:

Serena Group is recognized internationally as being in the forefront of research and innovative practice. Our large patient base affords us the ability to conduct clinical trials for all of the major pharmaceutical companies in the world. We conduct research at all of our wound care clinics, which has resulted in 75 published papers and over 175 presentations world wide.

Ancillary Benefits of Wound Care and Hyperbaric Medicine

Direct Savings in our Program

Cellulitis

Diabetic Foot Ulcer with infection

Pressure Ulcers - SerenaGroup™ Education and Prevention Program

Recent Observations in Hyperbaric Studies

At our Erie, PA, clinic, 39 year old woman presented with intractable diarrhea and abdominal pain resulting from radiation proctitis. The disease had failed to respond to standard out-patient treatment. The patient was hospitalized for parenteral nutrition and bowel rest. Hyperbaric oxygen therapy was initiated on the day of admission. After only 4 hyperbaric treatments, the patient was discharged to the clinic. After one additional week of Hyperbaric therapy, the patient’s proctitis had resolved. We have had similar outcomes with other patients suffering from the adverse effects of radiation therapy. The implications for reduced stay are clear.